Integra LifeSciences Holdings Corporation
http://www.integralife.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Integra LifeSciences Holdings Corporation
Integra LifeSciences Returns To Organic Growth After Rough Year With COVID-19
Integra's first-quarter revenue was up less than 3%, year over year, but the company reported the integration of the ACell regenerative technology business is ahead of schedule
FDA: Some Mesh Brands May Lead To More Complications In Breast Reconstruction Patients
Patients who receive breast reconstructive surgery using some brands of acellular dermal matrix seem to have a higher risk of major complications than those whose surgeries did not use the mesh, says a safety alert from the US FDA.
Orthopedic Roundup Q4: S&N, Stryker, J&J, Zimmer Biomet See Pandemic-Related Sales Impact
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Market Brief: Extremity Replacement Market Expected To Reach $2Bn By 2024
Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.
Company Information
- Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- ACell, Inc.
- Arkis BioSciences
- Ascension Orthopedics
- Confluent Surgical, Inc.
- Derma Sciences, Inc.
- IsoTis Orthobiologics, Inc.
- Minnesota Scientific
- Newdeal SA
- Omni-Tract Surgical
- Innovative Spinal Technologies Inc.
- Rebound Therapeutics
- TEI Biosciences Inc.
- TEI Medical Inc.
- Terragraphix, Inc.
- TGX Medical
- TGX Medical Systems, LLC
- MCF I LP THX Medical System LLC Holdings, Inc.